Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mississippi Center for Clinical and Translational Research
FIRST: Facilitating Independence in Research through Summer Training in CER
Social Attachment as a Model of Addiction
Low Density Lipoprotein in Free Radical Oxidative Damage
Gene Regulation in Phorbol Sensitive and Resistant Mice
Recently added grants:
Interaction of GCSF with the Endocannabinoid System in Promoting Brain Repair
Lymphangiogenesis in the pathogenesis of Acute Kidney Injury
Pathogenic role of thrombospondin-1 in acute and chronic liver failure
Functional Immunoimaging in the GI Tract
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-010
Application #
7191423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant